New York State Teachers Retirement System Sells 205 Shares of Encompass Health Co. (NYSE:EHC)

New York State Teachers Retirement System cut its holdings in shares of Encompass Health Co. (NYSE:EHC) by 0.3% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 75,902 shares of the company’s stock after selling 205 shares during the quarter. New York State Teachers Retirement System owned approximately 0.08% of Encompass Health worth $7,335,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. UMB Bank n.a. lifted its position in Encompass Health by 387.7% during the 3rd quarter. UMB Bank n.a. now owns 317 shares of the company’s stock worth $31,000 after buying an additional 252 shares in the last quarter. V Square Quantitative Management LLC lifted its position in Encompass Health by 53.0% during the 3rd quarter. V Square Quantitative Management LLC now owns 404 shares of the company’s stock worth $39,000 after buying an additional 140 shares in the last quarter. Oakworth Capital Inc. bought a new stake in Encompass Health during the 2nd quarter worth about $40,000. Benjamin F. Edwards & Company Inc. lifted its position in Encompass Health by 58.9% during the 2nd quarter. Benjamin F. Edwards & Company Inc. now owns 534 shares of the company’s stock worth $46,000 after buying an additional 198 shares in the last quarter. Finally, Point72 Asia Singapore Pte. Ltd. acquired a new position in shares of Encompass Health during the 2nd quarter worth about $58,000. 97.25% of the stock is owned by institutional investors.

Analyst Ratings Changes

Several research firms have recently weighed in on EHC. Barclays boosted their price objective on shares of Encompass Health from $109.00 to $116.00 and gave the stock an “overweight” rating in a research note on Tuesday, October 29th. Leerink Partners began coverage on shares of Encompass Health in a research note on Wednesday, July 10th. They set an “outperform” rating and a $100.00 price objective on the stock. Truist Financial restated a “buy” rating and set a $116.00 price objective (up from $108.00) on shares of Encompass Health in a research note on Wednesday, October 30th. UBS Group boosted their price objective on shares of Encompass Health from $100.00 to $110.00 and gave the stock a “buy” rating in a research note on Wednesday, September 25th. Finally, Leerink Partnrs upgraded shares of Encompass Health to a “strong-buy” rating in a research note on Wednesday, July 10th. Nine equities research analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Buy” and a consensus price target of $107.11.

Encompass Health Stock Performance

NYSE EHC opened at $100.23 on Tuesday. The company has a quick ratio of 1.35, a current ratio of 1.04 and a debt-to-equity ratio of 0.88. The company has a market capitalization of $10.09 billion, a P/E ratio of 24.21, a P/E/G ratio of 1.32 and a beta of 0.88. Encompass Health Co. has a 12-month low of $62.58 and a 12-month high of $102.36. The firm has a 50-day moving average price of $94.66 and a two-hundred day moving average price of $89.09.

Encompass Health (NYSE:EHC) last posted its quarterly earnings data on Monday, October 28th. The company reported $1.03 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.94 by $0.09. The firm had revenue of $1.35 billion during the quarter, compared to the consensus estimate of $1.33 billion. Encompass Health had a net margin of 8.10% and a return on equity of 17.60%. The business’s revenue for the quarter was up 11.9% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.86 EPS. Analysts anticipate that Encompass Health Co. will post 4.28 earnings per share for the current year.

Encompass Health Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, January 15th. Stockholders of record on Thursday, January 2nd will be issued a dividend of $0.17 per share. This represents a $0.68 dividend on an annualized basis and a dividend yield of 0.68%. The ex-dividend date of this dividend is Thursday, January 2nd. Encompass Health’s dividend payout ratio (DPR) is presently 16.43%.

Encompass Health declared that its Board of Directors has approved a stock buyback plan on Wednesday, July 24th that authorizes the company to repurchase $500.00 million in shares. This repurchase authorization authorizes the company to buy up to 5.4% of its shares through open market purchases. Shares repurchase plans are generally an indication that the company’s board of directors believes its shares are undervalued.

Insider Transactions at Encompass Health

In other news, CFO Douglas E. Coltharp sold 12,260 shares of the company’s stock in a transaction that occurred on Tuesday, August 13th. The shares were sold at an average price of $86.34, for a total transaction of $1,058,528.40. Following the completion of the sale, the chief financial officer now owns 136,227 shares of the company’s stock, valued at approximately $11,761,839.18. This represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. 2.10% of the stock is currently owned by insiders.

Encompass Health Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.